|
|
|
Insider
Information: |
Webster Stephen W |
Relationship: |
|
City: |
Exton |
State: |
PA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
44,447 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$533,818 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
44,447 |
|
|
Total
Value |
$533,818 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Adolor Corp |
ADLR |
SVP, Finance & CFO |
2011-12-12 |
0 |
2009-12-15 |
0 |
Premium* |
|
Optimer Pharmaceuticals Inc |
OPTR |
Chief Financial Officer |
2013-10-24 |
0 |
2012-06-29 |
0 |
Premium* |
|
Spark Therapeutics, Inc. |
ONCE |
CHIEF FINANCIAL OFFICER |
2019-12-17 |
0 |
2015-02-04 |
0 |
Premium* |
|
Nabriva Therapeutics AG |
NBRV |
Director |
2022-08-02 |
11,447 |
2018-05-23 |
0 |
Premium* |
|
Viking Therapeutics, Inc. |
VKTX |
Director |
2018-05-29 |
8,000 |
2018-05-29 |
0 |
Premium* |
|
Gritstone Oncology, Inc. |
GRTS |
|
2024-04-26 |
25,000 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
37 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ONCE |
Spark Therapeutics, Inc. |
Chief Financial Officer |
|
2018-01-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,750 |
4,250 |
0 |
- |
|
ONCE |
Spark Therapeutics, Inc. |
Chief Financial Officer |
|
2018-01-18 |
4 |
D |
$50.55 |
$32,099 |
D/D |
(635) |
3,615 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
Director |
|
2018-05-23 |
4 |
B |
$4.59 |
$36,720 |
D/D |
8,000 |
8,000 |
2.39 |
- |
|
VKTX |
Viking Therapeutics, Inc. |
Director |
|
2018-05-29 |
4 |
B |
$5.21 |
$41,712 |
D/D |
8,000 |
8,000 |
2.39 |
- |
|
ONCE |
Spark Therapeutics, Inc. |
Chief Financial Officer |
|
2019-01-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,750 |
6,731 |
0 |
- |
|
ONCE |
Spark Therapeutics, Inc. |
Chief Financial Officer |
|
2019-01-18 |
4 |
D |
$45.08 |
$56,936 |
D/D |
(1,263) |
6,102 |
0 |
- |
|
ONCE |
Spark Therapeutics, Inc. |
CHIEF FINANCIAL OFFICER |
|
2019-12-17 |
4 |
D |
$114.50 |
$698,679 |
D/D |
(6,102) |
0 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
Director |
|
2020-07-29 |
4 |
A |
$0.00 |
$0 |
D/D |
17,500 |
25,500 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
Director |
|
2021-07-28 |
4 |
A |
$0.00 |
$0 |
D/D |
17,500 |
20,050 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
Director |
|
2021-08-02 |
4 |
S |
$1.20 |
$932 |
D/D |
(777) |
19,273 |
0 |
- |
|
NBRV |
Nabriva Therapeutics AG |
Director |
|
2022-08-02 |
4 |
S |
$0.19 |
$1,487 |
D/D |
(7,826) |
11,447 |
0 |
- |
|
GRTS |
Gritstone Oncology, Inc. |
|
|
2024-04-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
25,000 |
|
% |
|
37 Records found
|
|
Page 2 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|